Full Text
The Impact Of Regulatory Accelerated Approval Schemes And Htas On Access To New Oncology Medicines- Evidence From 11 Countries

Abstract

Authors

P Kanavos V Tzouma C Flannelly

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×